BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25154199)

  • 21. A centralized Pharmacy Unit for cytotoxic drugs in accordance with Italian legislation.
    Baldo P; Bertola A; Basaglia G; Moneghini M; Sorio R; Zibardi E; Lazzarini R; De Paoli P
    J Eval Clin Pract; 2007 Apr; 13(2):265-71. PubMed ID: 17378874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of nursing management and utilization of nursing resources with the RAFAELA patient classification system--case study from the general wards of one central hospital.
    Rainio AK; Ohinmaa AE
    J Clin Nurs; 2005 Jul; 14(6):674-84. PubMed ID: 15946275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of antibiotic order form guiding rational use of expensive drugs on cost containment.
    Sirinavin S; Suvanakoot P; Sathapatayavongs B; Malatham K
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):636-42. PubMed ID: 10437971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbiological performance of a robotic system for aseptic compounding of cytostatic drugs.
    Geersing TH; Franssen EJF; Pilesi F; Crul M
    Eur J Pharm Sci; 2019 Mar; 130():181-185. PubMed ID: 30710619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inventory control: a review for hospital pharmacists.
    Noel MW
    Hosp Pharm; 1978 Nov; 13(11):617, 621-2, 624-5 passim. PubMed ID: 10239348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Management of cytostatic drugs by nurses: analysis of preliminary results].
    Bilski B
    Med Pr; 2004; 55(3):243-7. PubMed ID: 15493499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of the new handling recommendations for hazardous drugs in a hospital pharmacy service.
    García-Alcántara BG; Perelló Alomar C; Moreno Centeno E; Modamio P; Mariño EL; Delgado Sánchez O
    Farm Hosp; 2017 Mar; 41(2):257-269. PubMed ID: 28236800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ASHP national survey of hospital-based pharmaceutical services--1990.
    Crawford SY
    Am J Hosp Pharm; 1990 Dec; 47(12):2665-95. PubMed ID: 2278284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Drug supply chain safety in hospitals: current data and experience of the Grenoble university hospital].
    Bedouch P; Baudrant M; Detavernier M; Rey C; Brudieu E; Foroni L; Allenet B; Calop J
    Ann Pharm Fr; 2009 Jan; 67(1):3-15. PubMed ID: 19152845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug utilization and cost in a Medicaid population: a simulation study of community vs. mail order pharmacy.
    Valluri S; Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL
    BMC Health Serv Res; 2007 Jul; 7():122. PubMed ID: 17663768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Personnel time and preparation costs for compounded versus premixed intravenous admixtures in three community hospitals.
    Kirschenbaum BE; Cacace L; Anderson RJ; Ackerman LA
    Am J Hosp Pharm; 1988 Mar; 45(3):605-8. PubMed ID: 3369464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacy-laboratory interactions: a unique method to control antibiotic costs.
    Goff D; Thornton J
    Hosp Pharm; 1989 Jan; 24(1):26-9, 32. PubMed ID: 10291600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of the errors associated with the prescription, preparation and administration of cytostatic drugs].
    León Villar J; Aranda García A; Tobaruela Soto M; Iranzo Fernández MD
    Farm Hosp; 2008; 32(3):163-9. PubMed ID: 18840346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of adverse drug events and cost savings associated with PharmD interventions in an academic Level I trauma center: an evidence-based approach.
    Hamblin S; Rumbaugh K; Miller R
    J Trauma Acute Care Surg; 2012 Dec; 73(6):1484-90. PubMed ID: 23064610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chemotherapy registry quality in Andalusian hospital pharmacy departments].
    Peña J; Santos B; Briones E; Corbacho B; Fernández Feijóo A; Expósito J
    Farm Hosp; 2006; 30(6):370-3. PubMed ID: 17298194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence of exposure to cytostatic drugs in healthcare staff: a review of recent literature.
    Martín Lancharro P; De Castro-Acuña Iglesias N; González-Barcala FJ; Moure González JD
    Farm Hosp; 2016 Nov; 40(n06):604-621. PubMed ID: 27894231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive pharmaceutical services in the surgical suite and recovery room.
    Keicher PA; McAllister JC
    Am J Hosp Pharm; 1985 Nov; 42(11):2454-62. PubMed ID: 4073062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of non-medical factors on drug utilization in perinatal hospital practice].
    Miljković Z; Sabo A; Milasinovic L; Grujić I
    Med Pregl; 2000; 53(3-4):129-33. PubMed ID: 10965676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Centralized preparations of cytostatic agents: a method for quality control].
    Wernli M; Bögli F; Mühlebach S; Conen D
    Schweiz Med Wochenschr; 1994 Nov; 124(44):1962-5. PubMed ID: 7973528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delivery of pharmaceutical services at ward level in a teaching hospital.
    Schellack N; Martins V; Botha N; Meyer JC
    Curationis; 2009 Mar; 32(1):74-81. PubMed ID: 20225756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.